Life scientists are leaving academia for biotech, imperiling research – STAT

Home
News
Business
Washington
Science
Public Health
Disease
Features
Newsletters
Opinion
Columns
Podcasts
Video
Tools & Trackers
Events
Community
Don't miss out
Subscribe to STAT+ today, for the best life sciences journalism in the industry
By Jonathan Wosen
Nov. 15, 2023
Step inside Natasha Sheybani’s office at the University of Virginia, where she runs a bioengineering lab, and you’ll find a kaleidoscopic sea of sticky notes.
She uses purple for ideas sparked by meetings, orange for future grant proposals. But she’s most excited about the yellow stickies, which Sheybani saves for moonshots: projects that are high-risk and high-reward.
advertisement
For now, those are just thought experiments. “We actually are not doing those projects,” she said.
That’s because Sheybani has been unable to hire a postdoctoral researcher since starting her lab in 2021. She’s come tantalizingly close, twice, making offers that seemed like done deals. But in each case the candidate opted for a job at a biotech company.
She’s not alone. Academia is in the midst of an unprecedented exodus of life science researchers, many of whom are leaving for lucrative jobs in the private sector. STAT has written extensively about this seismic workforce shift over the past year, and new reporting reveals it’s already having a detrimental impact on basic research, slowing the pace of scientific progress. Faculty struggling to recruit and retain researchers spoke openly about promising hypotheses going untested, grant dollars sitting unused, and projects languishing in limbo for months to years.
Get unlimited access to award-winning journalism and exclusive events.
West Coast Biotech & Life Sciences Reporter
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter.
biotechnology
education
scientists
STAT+
Exciting news! STAT has moved its comment section to our subscriber-only app, STAT+ Connect. Subscribe to STAT+ today to join the conversation or join us on Twitter, Facebook, LinkedIn, and Threads. Let’s stay connected!
To submit a correction request, please visit our Contact Us page.
advertisement
Reporting from the frontiers of health and medicine
Company
Account
More
Become a STAT+ subscriber today!
Become a STAT+ subscriber today!
Unlimited access to essential biotech, medicine, and life sciences journalism
Become a STAT+ subscriber today!
Become a STAT+ subscriber today!
Your go-to source for the latest news and insights on biopharma and the life sciences
Become a STAT+ subscriber today!
Become a STAT+ subscriber today!
Unlimited access to essential biotech, medicine, and life sciences journalism
Become a STAT+ subscriber today!
Become a STAT+ subscriber today!
Your go-to source for the latest news and insights on biopharma and the life sciences

source

About The Author

admin

See author's posts